Dermata Therapeutics, Inc. DRMA
0.76 USD -0.09 (-10.87%)
At closeNov 6, 2026, 4:00 AM EST
0.78 +0.02 +1.98%
Pre-market · Nov 6, 4:00 AM ET
0.7617 Day range 0.85
0.603 52-week range 4.66
- YTD
- -67.16%
- 1 year
- -74.17%
Financial health
Altman Z-Score
-23.81 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
C+2 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 4
Valuation
P/E -0.3×
FY 2019 5y median -0.3× FY 2025
P/S 0.0×
FY 2019 5y median 0.0× FY 2025
P/B 0.3×
FY 2019 5y median 0.8× FY 2025
P/FCF -0.3×
FY 2019 5y median -0.3× FY 2025
EV/EBITDA 0.7×
FY 2019 5y median 0.1× FY 2025
EV/Sales 0.0×
FY 2019 5y median 0.0× FY 2025
FCF Yield -361.0%
FY 2019 5y median -361.0% FY 2025
Profitability
Gross Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2019 5y median 0.0% FY 2025
ROE -121.5%
FY 2019 5y median -122.7% FY 2025
ROIC -124.9%
FY 2019 5y median -126.5% FY 2025
ROA -96.1%
FY 2019 5y median -97.7% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2019 FY 2025
Operating Income 37.9%
FY 2019 FY 2025
EPS (diluted) 89.8%
FY 2019 FY 2025
Free Cash Flow 30.5%
FY 2019 FY 2025
Financial Health
Current Ratio 4.8×
FY 2019 5y median 4.9× FY 2025
Quick Ratio 4.8×
FY 2019 5y median 4.9× FY 2025
Debt / Equity 0.0×
FY 2019 5y median 0.0× FY 2025
Net Debt / EBITDA 1.0×
FY 2019 5y median 0.6× FY 2025
Interest Coverage 0.0×
FY 2019 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31